Tab 2 content
Andlin-Sobocki, P. J. (2005). Cost of disorders of the brain in Europe and US. . 1-27: Eur. J. Neurol. .
Ferguson AV, S. W. (2003). The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function . 141–50 : Front Neuroendocrinol .
Goadsby PJ, E. L. (1993). The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats . 48–56 : Annual Neurology .
Hans-Christoph Diener, A. C. (2015). New therapeutic approaches for the prevention and treatment of migraine . 1010-1022: Lancet Neurology .
Headache Classification Committee . (2004). The international classification of headache disorders. . 2nd ed. Cephalalgia Suppl. : International Headache Society .
Meng J, O. S. (2009). Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential. . Journal Neuroscience.
Messlinger K, L. J. (2012). CGRP and NO in the trigeminal system: mechanisms and role in headache generation . 1411–27. : Headache.
P Goadsby, J. L. (2007). Migraine prevalence, disease burden, and the need for preventive therapy. . 343–349: Neurology 68.
Rolan P, H. M. (2009). Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease . 2897–904 : Expert Opin Pharmacotherapy.
Migraines and Headaches… We’ve all had them!
Your typical, ordinary, normal NSAIDS like paracetamol just not cutting it anymore. Then continue reading to find out what innovative futuristic medications are currently being tested and how they work!